| 000 | 01931 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516064253.0 | ||
| 264 | 0 | _c20120710 | |
| 008 | 201207s 0 0 spa d | ||
| 022 | _a1578-8989 | ||
| 024 | 7 |
_a10.1016/j.medcli.2011.09.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlonso-García, Angeles | |
| 245 | 0 | 0 |
_a[Glycaemic management in type 1 and 2 diabetes patients undergoing interventional cardiology procedures. Heart and Diabetes Working Group. Sociedad Espan˜ola de Cardiologı´a. Sociedad Espan˜ola de Diabetes]. _h[electronic resource] |
| 260 |
_bMedicina clinica _cMar 2012 |
||
| 300 |
_a207.e1-5 p. _bdigital |
||
| 500 | _aPublication Type: Consensus Development Conference; English Abstract; Journal Article; Practice Guideline | ||
| 650 | 0 | 4 |
_aAcidosis, Lactic _xchemically induced |
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 |
_aBlood Glucose _xanalysis |
| 650 | 0 | 4 | _aCardiac Surgical Procedures |
| 650 | 0 | 4 |
_aContrast Media _xadverse effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDisease Management |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperglycemia _xetiology |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aInsulin _xadministration & dosage |
| 650 | 0 | 4 |
_aIntraoperative Complications _xprevention & control |
| 650 | 0 | 4 |
_aIodine Compounds _xadverse effects |
| 650 | 0 | 4 |
_aKidney Diseases _xcomplications |
| 650 | 0 | 4 |
_aMyocardial Ischemia _xcomplications |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 700 | 1 | _aMoreno Gómez, Raúl | |
| 700 | 1 | _aMiranda Guardiola, Faustino | |
| 700 | 1 | _aArtola-Menéndez, Sara | |
| 700 | 1 | _aLisbona-Gil, Arturo | |
| 773 | 0 |
_tMedicina clinica _gvol. 138 _gno. 5 _gp. 207.e1-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.medcli.2011.09.025 _zAvailable from publisher's website |
| 999 |
_c21320961 _d21320961 |
||